These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 17287171)
1. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Fan YZ; Fu JY; Zhao ZM; Chen CQ Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171 [TBL] [Abstract][Full Text] [Related]
2. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo. Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607 [TBL] [Abstract][Full Text] [Related]
3. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells. Fan YZ; Fu JY; Zhao ZM; Chen CQ Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):603-7. PubMed ID: 15567755 [TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo]. Fan YZ; Zhao ZM; Fu JY; Chen CQ Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):618-22. PubMed ID: 16784656 [TBL] [Abstract][Full Text] [Related]
5. [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism]. Fan YZ; Fu JY; Zhao ZM; Chen CQ Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):271-4. PubMed ID: 15312360 [TBL] [Abstract][Full Text] [Related]
6. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. Fan YZ; Fu JY; Zhao ZM; Chen CQ World J Gastroenterol; 2005 Apr; 11(16):2431-7. PubMed ID: 15832413 [TBL] [Abstract][Full Text] [Related]
7. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms]. Fan YZ; Chen CQ; Zhao ZM; Sun W Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930 [TBL] [Abstract][Full Text] [Related]
8. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564 [TBL] [Abstract][Full Text] [Related]
9. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway. Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713 [TBL] [Abstract][Full Text] [Related]
10. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro. Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772 [TBL] [Abstract][Full Text] [Related]
11. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells. Yu CC; Ko FY; Yu CS; Lin CC; Huang YP; Yang JS; Lin JP; Chung JG Int J Oncol; 2012 Sep; 41(3):1050-60. PubMed ID: 22684608 [TBL] [Abstract][Full Text] [Related]
12. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632 [TBL] [Abstract][Full Text] [Related]
13. [Effect of norcantharidin's derivative Nd3 on proliferation of human ovarian cancer cell line SKOV3 and its possible mechanisms]. Cao JH; Xu B; Li M; Wu DZ; Huang W; Cui JR Ai Zheng; 2007 Apr; 26(4):361-6. PubMed ID: 17430652 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro]. Liu Y; Zahng J; You Z; Liao H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):824-8. PubMed ID: 25108435 [TBL] [Abstract][Full Text] [Related]
15. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells. Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130 [TBL] [Abstract][Full Text] [Related]
16. Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells. Ye K; Wei Q; Gong Z; Huang Y; Liu H; Li Y; Peng X Ren Fail; 2017 Nov; 39(1):458-464. PubMed ID: 28393592 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway. Wang H; Sun W; Zhang WZ; Ge CY; Zhang JT; Liu ZY; Fan YZ PLoS One; 2014; 9(5):e96982. PubMed ID: 24811250 [TBL] [Abstract][Full Text] [Related]
18. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro. Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524 [TBL] [Abstract][Full Text] [Related]
19. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo. Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792 [TBL] [Abstract][Full Text] [Related]
20. Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma. Yang H; Guo W; Xu B; Li M; Cui J Anticancer Drugs; 2007 Nov; 18(10):1133-7. PubMed ID: 17893513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]